Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$44,162,325
+$14,901,120 QoQ
Shares Held
518,398
+16.8% QoQ
Ownership
0.373%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#59
of 477 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 86%
Shared 14%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. CYTK ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in CYTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,162,325 | 518,398 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $29,261,205 | 443,957 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,206,041 | 443,910 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $23,588,996 | 429,203 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $14,297,432 | 432,731 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $14,524,183 | 361,388 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,773,335 | 356,576 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $17,368,929 | 328,957 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,957,635 | 331,444 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $29,155,523 | 415,854 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $80,734,830 | 967,000 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $65,570,948 | 2,225,762 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $88,883,693 | 2,724,822 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $94,263,382 | 2,678,698 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $54,150,854 | 1,181,817 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $22,449,065 | 463,345 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,293,179 | 440,142 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,097,731 | 410,153 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $18,983,933 | 416,497 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $12,473,009 | 348,993 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||